1. Home
  2. PZZA vs OABI Comparison

PZZA vs OABI Comparison

Compare PZZA & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Papa John's International Inc.

PZZA

Papa John's International Inc.

N/A

Current Price

$19.70

Market Cap

640.7M

ML Signal

N/A

Logo OmniAb Inc.

OABI

OmniAb Inc.

N/A

Current Price

$4.78

Market Cap

696.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PZZA
OABI
Founded
1984
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
640.7M
696.4M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
PZZA
OABI
Price
$19.70
$4.78
Analyst Decision
Hold
Strong Buy
Analyst Count
13
7
Target Price
★ $29.00
$8.33
AVG Volume (30 Days)
★ 1.4M
1.2M
Earning Date
11-05-2026
11-03-2026
Dividend Yield
★ 7.09%
N/A
EPS Growth
N/A
★ 6.56
EPS
★ 0.46
N/A
Revenue
★ $2,068,421,000.00
$18,666,000.00
Revenue This Year
N/A
$87.73
Revenue Next Year
N/A
$25.31
P/E Ratio
$42.30
★ N/A
Revenue Growth
★ 14.07
N/A
52 Week Low
$18.92
$1.32
52 Week High
$55.74
$5.43

Technical Indicators

Market Signals
Indicator
PZZA
OABI
Relative Strength Index (RSI) 35.92 56.20
Support Level $19.31 $1.71
Resistance Level $24.25 $5.06
Average True Range (ATR) 0.62 0.35
MACD 0.18 -0.05
Stochastic Oscillator 32.88 66.67

Price Performance

Historical Comparison
PZZA
OABI

About PZZA Papa John's International Inc.

Papa John's International Inc operates and franchises pizza delivery and carryout restaurants and, in certain international markets, dine-in and delivery restaurants. It has four defined reportable segments: Domestic Company-owned restaurants, North America franchising, North America commissaries, and International. The company derives maximum revenue from North America commissaries segment. The North America commissaries segment consists of the operations of its regional dough production and product distribution centers in the United States and Canada and derives its revenues principally from the sale and distribution of food and paper products to Domestic Company-owned and franchised restaurants in the United States and Canada.

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Share on Social Networks: